S.B. 317: Opioid Terminology Amendments
1 recorded floor vote in the 2026 General Session. The bill's official page has its text, sponsors, committee votes and full history.
About this bill
Did not pass both chambers; the bill was filed on March 6, 2026. This bill addresses terminology related to opioids.
- Makes the following changes throughout the code and makes related, conforming changes: changes the defined term "opiate" to "opioid-like substance"; changes the defined term "opiate antagonist" to "opioid antagonist"; and changes the defined term "opiate-related drug overdose event" to "opioid-related drug overdose event"
- Changes the term "opiate" to "substance" in the description of certain controlled substances
- Includes coordination clauses to coordinate changes in this bill and H.B. 301, Drug Recodification, S.B. 87 Naloxone Amendments, and S.B. 98 Substance Use Rehabilitation Amendments
- Defines terms
- Makes technical and conforming changes
Utah Senate, March 3, 2026
2nd Reading, Passage on 2nd & 3rd Under suspension of the rules · 1st Sub. SB 317
Result as recorded: Passed, Ayes 26 Nays 0 Abs 3
Yes (26)
- Ann Millner
- Brady Brammer
- Chris H. Wilson
- Daniel McCay
- David P. Hinkins
- Derrin R. Owens
- Don L. Ipson
- Emily Buss
- Evan J. Vickers
- Heidi Balderree
- J. Stuart Adams
- Jen Plumb
- Jerry W Stevenson
- John D. Johnson
- Karen Kwan
- Kathleen A. Riebe
- Keith Grover
- Keven J. Stratton
- Luz Escamilla
- Michael K. McKell
- Nate Blouin
- Ronald M. Winterton
- Scott D. Sandall
- Stephanie Pitcher
- Todd Weiler
- Wayne A. Harper